Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

CAMBRIDGE, Mass. & MONTREAL -- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the appointment of Steven H. Stein, M.D., to its Board of Directors, effective as of the date of the Company’s upcoming annual meeting of shareholders in June 2024. The Company also announces that Todd Foley has decided not to stand for re-election as a director of the Company following the end of his current term as a Class I director on June 17, 2024, after serving more than seven years on the Board. Read More

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors

Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors